Evidence map›Paper›PMID 41635835›Full record

ArticleJournal of diabetes research2026

Genetically Modified

Masahiro Yoda, Natsumi Nomura, Shoko Yoda, Mao Kagotani, Aito Murakami, Fu Namai, Tadashi Fujii, Takumi Tochio, Takashi Sato, Takeshi Shimosato

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of diabetes research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Genetically ModifiedJournal of diabetes research · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Masahiro YodaGraduate School of Medicine, Science and Technology, Shinshu University, Nagano, Japan, shinshu-u.ac.jp.
Natsumi NomuraDepartment of Agriculture, Graduate School of Science and Technology, Shinshu University, Nagano, Japan, shinshu-u.ac.jp.
Shoko YodaInstitute for Aqua Regeneration, Shinshu University, Nagano, Japan, shinshu-u.ac.jp.
Mao KagotaniDepartment of Agriculture, Graduate School of Science and Technology, Shinshu University, Nagano, Japan, shinshu-u.ac.jp.
Aito MurakamiInstitute for Aqua Regeneration, Shinshu University, Nagano, Japan, shinshu-u.ac.jp.
Fu NamaiGraduate School of Medicine, Science and Technology, Shinshu University, Nagano, Japan, shinshu-u.ac.jp.
Tadashi FujiiDepartment of Medical Research on Prebiotics and Probiotics, Fujita Health University, Toyoake, Aichi, Japan, fujita-hu.ac.jp.
Takumi TochioInstitute for Aqua Regeneration, Shinshu University, Nagano, Japan, shinshu-u.ac.jp.
Takashi SatoInstitute for Aqua Regeneration, Shinshu University, Nagano, Japan, shinshu-u.ac.jp.
Takeshi ShimosatoGraduate School of Medicine, Science and Technology, Shinshu University, Nagano, Japan, shinshu-u.ac.jp.ORCID https://orcid.org/0000-0001-8132-1911

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder and typically develops later in life due to systemic dysfunction in metabolic homeostasis and various factors related to

Indexed as

Blood GlucoseGastrointestinal MicrobiomeGlucoseInterleukin 1 Receptor Antagonist ProteinLactococcus lactisObesityAnimalsCell LineDiabetes Mellitus, Type 2Disease Models, AnimalInsulin-Secreting CellsMaleMiceMice, Inbred C57BLMice, ObeseBlood GlucoseGlucoseInterleukin 1 Receptor Antagonist Proteindiet-induced obese mouse modelglucose metabolismgmLABIL-1RaIL-1βmicrobiota

Identifiers

PMID41635835
PMCPMC12862108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.